121 related articles for article (PubMed ID: 32007760)
1. Hospital variance in neoadjuvant rectal cancer treatment and the influence of a national guideline update: Results of a nationwide population-based study.
Koëter T; Elferink MA; Verhoeven RHA; Zimmerman DDE; Wasowicz DK; Verheij M; de Wilt JHW
Radiother Oncol; 2020 Apr; 145():162-171. PubMed ID: 32007760
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
3. Trends and Variation in the Use of Radiotherapy in Non-metastatic Rectal Cancer: a 14-year Nationwide Overview from the Netherlands.
Verrijssen AE; Evers J; van der Sangen M; Siesling S; Aarts MJ; Struikmans H; Bloemers MCWM; Burger JWA; Lemmens V; Braam PM; Elferink MAG; Berbee M
Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):221-232. PubMed ID: 38336504
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
5. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
6. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
7. Hospital volume and outcome in rectal cancer patients; results of a population-based study in the Netherlands.
Hagemans JAW; Alberda WJ; Verstegen M; de Wilt JHW; Verhoef C; Elferink MA; Burger JWA
Eur J Surg Oncol; 2019 Apr; 45(4):613-619. PubMed ID: 30600101
[TBL] [Abstract][Full Text] [Related]
8. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
Detering R; Borstlap WAA; Broeders L; Hermus L; Marijnen CAM; Beets-Tan RGH; Bemelman WA; van Westreenen HL; Tanis PJ;
Ann Surg Oncol; 2019 Feb; 26(2):437-448. PubMed ID: 30547330
[TBL] [Abstract][Full Text] [Related]
9. Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer.
Marin G; Suárez J; Vera R; Balén E; Viudez A; Mata E
Int J Surg; 2017 Aug; 44():15-20. PubMed ID: 28583894
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?
Imam I; Hammarström K; Sjöblom T; Glimelius B
Radiother Oncol; 2021 Apr; 157():70-77. PubMed ID: 33453311
[TBL] [Abstract][Full Text] [Related]
11. Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision.
Detering R; de Neree Tot Babberich MPM; Bos ACRK; Dekker JWT; Wouters MWJM; Bemelman WA; Beets-Tan RGH; Marijnen CAM; Hompes R; Tanis PJ;
Eur J Surg Oncol; 2020 Mar; 46(3):486-494. PubMed ID: 31882252
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
[TBL] [Abstract][Full Text] [Related]
13. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial.
Latkauskas T; Pauzas H; Kairevice L; Petrauskas A; Saladzinskas Z; Janciauskiene R; Gudaityte J; Lizdenis P; Svagzdys S; Tamelis A; Pavalkis D
BMC Cancer; 2016 Dec; 16(1):927. PubMed ID: 27903247
[TBL] [Abstract][Full Text] [Related]
14. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study.
Wasmuth HH; Rekstad LC; Tranø G
Colorectal Dis; 2016 Jan; 18(1):67-72. PubMed ID: 26201935
[TBL] [Abstract][Full Text] [Related]
15. Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
Gietelink L; Wouters MWJM; Marijnen CAM; van Groningen J; van Leersum N; Beets-Tan RGH; Tollenaar RAEM; Tanis PJ;
Eur J Surg Oncol; 2017 Jul; 43(7):1297-1303. PubMed ID: 28351504
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
17. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
[TBL] [Abstract][Full Text] [Related]
18. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.
Sorrentino L; Guaglio M; Battaglia L; Bonfanti G; Vitellaro M; Bianchi AC; Milione M; Belli F
Int J Colorectal Dis; 2019 Dec; 34(12):2161-2169. PubMed ID: 31741026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
